Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in
device-based hypertension therapies | European Heart Journal | Oxford Academic Skip to Main …

Key enablers that have supported DSD for HIV such as simplified algorithms, optimized
formulations, secure drug supply, and strengthened monitoring and evaluation systems are …

Background The gains from successful antiretroviral therapy (ART) roll-out could be
compromised by the increasing burden of non-communicable diseases, particularly …

Introduction Hypertension among HIV positive patients in low-and middle-income countries
has got little attention and data on the problem is limited in Ethiopia. Hence, this study aims …

Background As the human immunodeficiency virus (HIV) treatment landscape continues to
evolve, the prolonged life expectancy and long-term exposure to antiretroviral drugs have …

Introduction: HIV is an independent risk factor for cardiovascular diseases (CVD). There is
insufficient information regarding comorbidities and cardiovascular risk factors in the …

Studies show that treatment outcomes may vary among persons living with HIV. To fast-track
the attainment of epidemic control across gender and age groups, the Accelerating Control …

2 METHODS This was a follow‐up study of participants from the Malaysian HIV and Aging
(MHIVA) cohort where participants under routine care at the Infectious Diseases Unit …

Objectives: Uncontrolled hypertension is a main predisposing risk factor leading to chronic
atrial fibrillation (AF). Although several treatment methods for patients with HTN and AF were …

Abstract Background The Nigerian HIV Geriatric Cohort (NHGC) is a longitudinal cohort
setup to learn how elderly people living with HIV (EPLHIV) in Nigeria fare, despite not being …